OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use

<p>The OnabotulinumtoxinA in Chronic Migraine Adis Drug Q&A video abstract, script and image slide deck provide a brief overview of the mechanism of action of onabotulinumtoxinA in chronic migraine, the administration regimen and the key efficacy and tolerability outcomes from clinical trials and real world studies.</p><p><br></p><p>The video abstract, script and slide deck, which have been peer reviewed and were uploaded to Figshare after the OnabotulinumtoxinA in Chronic Migraine Adis Drug Q&A was published, are sponsored by AbbVie.<br></p><p><br></p><p>The video abstract can be found <a href="https://figshare.com/articles/online_resource/OnabotulinumtoxinA_in_Chronic_Migraine_A_Profile_of_Its_Use/13218869">here</a>.</p><p><br></p><p><br></p><p>© Springer Nature Switzerland AG 2021<br></p>